What the Phase 2 Trial Arms Looked Like The table below records what was administered in that trial and the least-squares mean changes reported at 48 weeks a record of past research, not a protocol
The Jillian Michaels version swaps the salt for apple cider vinegar and comes in at about 45 kcal
When you factor in the superior weight loss (which reduces obesity-related healthcare costs), fewer injections (which reduces supply costs), and better metabolic outcomes, tirzepatide provides more value per dollar spent, even at comparable or higher monthly prices
I originally lost 40 pounds, but when I stopped the medication cold turkey with no guidance or support, I gained every pound back
Off-Label Use: Some medications are prescribed off-label for weight loss: Semaglutide (Ozempic): FDA-approved for type 2 diabetes (not weight loss) Identical to Wegovy but different indication Commonly prescribed off-label for weight loss Same effectiveness as Wegovy Tirzepatide (Mounjaro): FDA-approved for type 2 diabetes (not weight loss) Identical to Zepbound but different indication Prescribed off-label for weight loss before Zepbound approval Same effectiveness as Zepbound Metformin: Diabetes medication sometimes used for weight loss Produces only 1-3% weight loss Not FDA-approved for weight loss Generally not recommended as primary weight loss medication The Current State of Weight Loss Medication: Clear Winners: GLP-1 receptor agonists (especially tirzepatide and semaglutide) have become the gold standard for medical weight loss, producing results previously unattainable with medication alone
A new study found GLP-1 medications may help lower mortality risk for people who have colon cancer, a type of colorectal cancer
